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INTRODUCTION
Patients in the intensive care unit (ICU) are likely to suffer
from acute respiratory failure (ARF) with a risk of develop-
ing acute lung injury (ALI) and its more severe complica-
tion, acute respiratory distress syndrome (ARDS) with
30–50% mortality (Bernard et al., 1994; Ferguson et al.,
2007). Hospital mortality in Scandinavia decreased by 1%
per year (p = 0.03) during the studied period held, from
50% in 1988–1992 to 33% in 2006–2010. The ten-year sur-
vival of ARDS survivors was 68% compared with 90% sur-
vival of a reference population (p < 0.001). The incidence
of ARDS has almost doubled, but hospital mortality was
shown to decrease since 1990 during 23 years of observa-
tion in Scandinavia (Sigurdsson et al., 2013).
Patients with ARF, and particularly those diagnosed with
ARDS, represent a great economic burden, because of the
requirement of long-lasting and possibly harmful ventilator
support, eventually including extracorporeal membrane
oxygenation (ECMO) and other advanced management
techniques.
The acute respiratory distress syndrome (ARDS) is common
and multi factorial, clinically described as an inflammatory
lung disorder, which is associated with great morbidity and
high mortality in intensive care patients. An important role
in developing of ARDS may by played by a disbalance be-
tween reactive oxygen species (ROS), which have both oxi-
dant and antioxidant compartments. The pathogenesis of
ARDS is very complex, and unfortunately, the dynamic de-
velopment of ARDS in an individual patient is difficult to
recognise. That is the reason why predicting development of
ARDS has great value for intensive care specialists.
DEFINITIONS
During the last two decades, ALI and ARDS have been de-
fined according to the American–European Consensus Con-
ference (AECC) criteria, where ARDS was diagnosed as a
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Acute respiratory distress syndrome (ARDS) is common and multi factorial, clinically described as
an inflammatory lung disorder that is associated with major morbidity and high mortality in inten-
sive care patients. Recently, investigators have revised the AECC criteria from 1994. To diagnose
ARDS and discover its severity we presently use Berlin definition criteria. An important role in de-
veloping of ARDS may be through a disbalance between reactive oxygen species (ROS), which
have both oxidant and antioxidant compartments. The pathogenesis of ARDS is very complex,
and unfortunately, the dynamic development of ARDS in an individual patient is difficult to recog-
nise. ROS can initiate cellular tissue damage by modifying lipids, proteins and DNA, which can
seriously compromise cell life ability or induce a large number of cellular responses through gen-
eration of secondary reactive species, leading, at last, to cell death by necrosis or apoptosis.
Studies have shown that many patients with organ malfunction at admission to the intensive care
units (ICU) show decreased antioxidative properties, worsening the harmful effects of lipid peroxi-
dation. That is the reason why predicting development of ARDS has great value for intensive care
specialists.
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“syndrome of inflammation and increased permeability that
is associated with a constellation of clinical, radiologic, and
physiologic abnormalities that cannot be explained by, but
may coexist with, left atrial or pulmonary capillary hyper-
tension” (Bernard et al., 1994). In short, the definition is
based on the following criteria: (1) acute onset; (2)
PaO2/FIO2 < 300 mm Hg for ALI and PaO2/FIO2 < 200
mm Hg for ARDS; (3) bilateral infiltrates on the frontal
chest radiograph; and (4) pulmonary artery pressure < 18
mm Hg, or no clinical evidence of left atrial hypertension
(Bernard et al., 1994) (Table 1).
The severity of the disease was evaluated using Murray
lung injury score (Table 2).
In 1988, Murray and colleagues proposed an expanded defi-
nition of ARDS, taking into account various pathophysio-
logical features of the clinical syndrome (Murray et al.,
1988). The Murray scoring system includes four criteria for
the development of ALI/ARDS: a “scoring” of hypoxemia,
a “scoring” of respiratory system compliance, chest radio-
graphic findings, and level of positive end-expiratory pres-
sure. Each criterion receives a score from 0 to 4 according
to the severity of the condition. The final score is obtained
by dividing the collective score by the number of compo-
nents that were used. A score of zero indicates no lung in-
jury, a score of 1–2.5 indicates mild to moderate lung in-
jury, and a final score of more than 2.5 indicates the
presence of acute respiratory distress syndrome (Murray et
al., 1988).
Recently, investigators have revised the AECC criteria from
1994 (Bernard et al., 1994; Ranieri et al., 2012). The AECC
definition required that onset of respiratory failure is acute,
without indicating a specific timeframe (e.g., hours, days, or
weeks). In a study by Fergusson et al. (2005), during the pe-
riod of acceptance, when the criteria were strictly applied
(bilateral chest X-ray infiltrates) in routine work, the sensi-
tivity remained at 84%, but the specificity was at only 51%.
Acute lung injury, as in a subgroup with a milder hypoxe-
mia (i.e., with PaO2/FiO2 201–300 mmHg) was suggested
to be under-recognised by clinicians. The clinicians con-
cluded that PaO2/FiO2 may vary with FiO2, and in response
to differences in ventilator settings, particularly to varia-
tions in PEEP.
Since PEEP can affect the reliability and specificity of
PaO2/FiO2 to classify the severity of ARDS, a minimum
PEEP level of 5 cm H2O (or non-invasive CPAP for mild
ARDS) has been included in the updated Berlin definition,
where ALI is defined as mild form of ARDS, as shown in
Table 3 (Ranieri et al., 2012). Table 3 distinguishes three
different stages (mild, moderate, and severe) of ARDS to
provide better and more precise separation of prognosis and
interventional decisions. Several observational studies sug-
gest that the majority of patients are identified within 72 h
of the recognition of underlying risk factors, with nearly all
patients identified within seven days. The meaning of
“acute onset” has been redefined as a condition developing
within one week of a known clinical insult or new/worsen-
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T a b l e 1
AMERICAN–EUROPEAN CONSENSUS CONFERENCE ON ARDS:
RECOMMENDED CRITERIA FOR ACUTE LUNG INJURY AND
ACUTE RESPIRATORY DISTRESS SYNDROME
Injury Criteria
ALI Acute onset
PaO2/FiO2  300 mm Hg
Bilateral infiltrates on frontal chest radiograph
Pulmonary artery wedge pressure  18 mm Hg (when mea-
sured), or no clinical
evidence of left atrial hypertension
ARDS Acute onset
PaO2/FiO2  200 mm Hg
Bilateral infiltrates on frontal chest radiograph
Pulmonary artery wedge pressure  18 mm Hg (when mea-
sured), or no
clinical evidence of left atrial hypertension
ALI, acute lung injury; ARDS, acute respiratory distress syndrome; PaO2,
arterial oxygen tension; FiO2, fraction of inspired oxygen.
T a b l e 2
THE LUNG INJURY SCORE (Murray score)
1. Chest radiogram score
No alveolar consolidations 0
Alveolar consolidation confined to 1 quadrant 1
Alveolar consolidation confined to 2 quadrant 2
Alveolar consolidation confined to 3 quadrant 3
Alveolar consolidation confined to 4 quadrant 4
2. Hypoxemia score




PaO2/FiO2 < 100 4
3. PEEP score (when ventilated)
PEEP  5 cmH2O 0
PEEP 6–8 cmH2O 1
PEEP 9–11 cmH2O 2
PEEP 12–14 cmH2O 3
PEEP  15 cmH2O 4
4. Respiratory system compliance score (when available)
Compliance  80 ml/ cmH2O 0
Compliance 60–79 ml/ cmH2O 1
Compliance 40–59 ml/ cmH2O 2
Compliance 20–39 ml/ cmH2O 3
Compliance  19 ml/ cmH2O 4
The final value is obtained by dividing the ag-
gregate sum by the number of components that
were used.
No lung injury






PaO2 / FiO2, arterial oxygen tension to inspired oxygen concentration ratio;
PEEP, positive end expiratory pressure.
ing of already existing respiratory failure. Another concern
is that the chest X-ray criterion has moderate inter-observer
reliability, even among experts (Ranieri et al., 2012; Meade
et al., 2000). To make the chest radiograph criterion more
clear, it should include “diffuse” bilateral opacities consis-
tent with pulmonary oedema, which are not fully explained
by effusions, lung collapse, or nodules/masses. On the other
hand, CT scan abnormalities are not included in the defini-
tion (Table 3).
Etiology. ARDS is a multi-factorial disease that may occur
due to environmental causing factors in genetically predis-
posed critically ill individuals.
ALI and ARDS can develop due to pulmonary (direct) or
extrapulmonary (indirect) reason. Direct ALI causes (pneu-
monia, aspiration of gastric content, contusion, embolus, in-
halation injury and reperfusion) account for approximately
55% of all ALI cases, and indirect ALI (extrapulmonary
sepsis and trauma, burn injury, mass transfusion of blood
components, bypass surgery, intoxication and acute pan-
creatitis) account for 20%. In one-fifth of all patients, there
appear to be mixed factors leading to ALI and the remain-
ing 4% actually cannot be explained by any underlying pa-
thophysiology. Sepsis is the most commonly encountered
condition among all mentioned underlying the development
of ALI, with severe sepsis accounting for 46% of direct and
33% of indirect ALI cases (Perl et al., 2011).
PATHOPHYSIOLOGY
The pathology leading to ALI/ARDS has not been well un-
derstood until recently. It is likely to be as heterogeneous as
the underlying conditions that induce them.
Oxidative or, in other words, nitrosative stress is a condition
that is characterised by increased levels of reactive oxygen
species. It is recognised to be one of the most important fea-
tures of many acute and chronic diseases, not only in the ag-
ing process.
As mentioned above, generation of reactive oxygen species
(ROS) in lung infection plays a significant role in develop-
ment of ARDS and worldwide attention to this has tended
to increase, since many physiological and pathophysiologi-
cal conditions are related to oxidative-antioxidative cell
modification. A free radicals can be defined as chemical
substances containing unpaired electrons and that are par-
amagnetic. Most of the oxygen derived free radicals are un-
stable molecules, short-lived and highly reactive. For these
reasons, ROS can initiate cellular tissue damage by degrad-
ing lipids, proteins and DNA, which can seriously influence
cell life ability or induce a large number of cellular re-
sponses due to generation of secondary reactive species,
leading to cell death by necrosis or apoptosis.
Free radicals can be removed by some metalloenzymes
(e.g., superoxide dismutase, glutathione peroxidase, and
catalase) as well as by the non-enzymatic antioxidant pro-
tective system (e.g., tocopherol, -carotene, glutathione,
lipoic acid, and uric acid), the main function of which is to
reduce their chemical activity.
Another important process in oxidative stress formation is
lipid peroxidation. This is a complex process whereby poly-
unsaturated fatty acids in phospholipids of cellular mem-
branes undergo reaction with oxygen to form lipid perox-
ides and hydroperoxides (LH, LOOH). The LOOH and
conjugated dienes that are formed can decompose to form a
variety of other products, including alkanals, alkenals,
hydroxyalkenals, malondialdehyde (MDA), reactive car-
bonyl intermediates, such us ,-unsaturated aldehydes-
4-hydroxinonenal (4-HNE) and volatile hydrocarbons.
Malondialdehyde is an indicator that can be used to detect
lipid peroxidation. Another indicator might be thio-
barbituric acid (TBA), which together with MDA can form
a complex MDA_TBA, which could be related to the activ-
ity of oxidative stress in ARDS patients. However, MDA is
regarded to be an unspecific marker of lipid peroxidation
due to analytical difficulties, and thus in combination with
TBA it may be more specific (Lapenna et al., 2001). Vola-
tile aldehydes have been studied as specific markers of lipid
peroxidation in asthma/chronic obstructive pulmonary dis-
ease (Corradi et al., 2004) and ARDS (Weigand et al.,
2004). Aldehydes of all types are considered as toxic sec-
ond messengers, due to their ability to react with protein
molecules. This may result in severe damage caused by loss
of enzyme activity, destruction of amino acids and polymer-
ization, as well as genotoxicity induced by binding to DNA
(Valko et al., 2006).
In a study (Lichtenstern et al., 2009) comparing ARDS and
liver failure patients, MDA levels were more than four
times higher in arterial and mixed venous blood of ARDS
patients than those of patients who suffered from liver in-
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T a b l e 3
THE BERLIN DEFINITION OF ARDS*
Acute Respiratory Distress Syndrome
Timing Within 1 week of a known clinical insult or new or
worsening respiratory symptoms
Chest imaginga Bilateral opacities — not fully explained by effusions,
lobar/lung collapse, or nodules
Origin of edema Respiratory failure not fully explained by cardiac fail-
ure or fluid overload. Need objective assessment (e.g,
echocardiography) to exclude hydrostatic edema if no
risk factor presented
Oxygenationb Mild — 200 mm Hg  PaO2/FiO2  300 mm Hg with
CPAP or PEEP  5 cm H2O
c
Moderate —100 mm Hg  PaO2/FiO2  200 mm Hg
with PEEP  5 cm H2O
Severe — PaO2/FiO2  100 mm Hg with PEEP  5 cm
H2O
* Ranieri et al., 2012. CPAP, continuous positive airway pressure; FiO2,
fraction of inspired oxygen; PaO2, partial pressure of arterial oxygen;
PEEP, positive end- expiratory pressure; a, chest radiograph or computed
tomography scan; b, if altitude is higher than 1000m, the correction factor
should be calculated as follows: (PaO2/FiO2 x (barometric pressure/ 760));
c, this may be delivered noninvasively in the mild acute respiratory distress
syndrome group.
sufficiency. There was no difference detectable for MDA
concentrations in arterial and mixed venous blood of ARDS
patients (p = 0.78). However, in the ARDS group, both
volatile aldehydes showed much higher arterial than mixed
venous levels, representing significant gradients between
both compartments (Lichtenstern et al., 2009).
In sepsis patients, a significant increase of MDA levels was
observed to develope, compared to those in burn trauma pa-
tients, on the second day (Mühl et al., 2011). Lipid peroxi-
dation reaction in biological membranes causes the impair-
ment of membrane functioning, because of inactivation of
membrane-bound receptors and enzymes, as well as in-
creased non-specific permeability to ions (Palmieri et al.,
2007).
It has been shown that many patients with organ malfunc-
tion at admission to intensive care units (ICU) show im-
paired antioxidative properties, worsening the harmful ef-
fects of lipid peroxidation. For this reason, antioxidative
nutrients such as selenium may be beneficial in the treat-
ment of critical ill patients (Heyland et al., 2005).
A dominant role in ARDS pathophysiology is played by im-
balance between oxidant and antioxidant species. Previous
studies have shown that decreased concentrations of water-
soluble antioxidants (urate, glutathione, ascorbate) are pres-
ent in the distal airways in patients with ALI (Bowler et al.,
2003).
Elevated concentrations of hydrogen peroxide (Baldwin et
al., 1986; Sznajder et al., 1989) as well as isoprostanes
(Carpenter et al., 1998) due to peroxidation of membrane
phospholipids in vivo have been observed in the exhaled
breath condensate in ARDS patients. This group of patients
showed a significant decrease of antioxidants like -toco-
pherol and selenium, while the level of lipid peroxidation in
plasma was increased (Richard et al., 1990; Quinlan et al.,
1996; Metnitz et al., 1999; Kumar et al., 2000)
In patients with recognised distress syndrome, concentra-
tions of lipid peroxides are significantly higher, compared
to those in controls and patients who are at risk for develop-
ing ARDS (Kumar et al., 2000). Moreover, patients at risk
for ARDS or with already diagnosed syndrome showed a
significant decrease in polyunsaturated fatty acids (PUFA),
representing an important fatty acid deficiency disease
(Gutteridge et al., 1998). Kumar et al. (2000) showed a sig-
nificant decrease in the levels of nitric oxide in patients with
established ARDS.
As part of ARDS pathophysiology, accumulation of neutro-
phils has been observed, which is important in patients with
developing acute lung injury (Lee et al., 2001). The physi-
ologic role of neutrophils can be characterised not only by
production and release of ROS, but also by release of prote-
ases favouring pathogen translocation. Effective neutralisa-
tion of neutrophil proteases and free radicals by lung anti-
oxidants (glutathione) and antiproteases (a1-antitrypsin,
a2-macroglobulin) can possibly prevent developing lung in-
jury.
Inflammation of the lung may result in activation of macro-
phages and neutrophils, which indicates the release of free
radicals due to respiratory burst. In addition, commonly
used high inspiratory concentrations of oxygen may contrib-
ute to generation of free radicals (Lang et al., 2002), not
only in critically ill patients, but also during long general
anaesthesia. This shows a dependence of oxidative stress
markers on ventilation strategy, which is used in treatment
of patients with acute respiratory failure.
Another aspect that should be considered is that the mode of
ventilation during ARDS may also influence antioxidant
gene expression followed by antioxidant release. The mode
of ventilation has a proved impact on gene expression in
lung tissue, as it has been observed that a non-ventilated
lung had increased levels of proinflammatory genes (e.g.
interleukin-1b) in bronchial epithelium cells after high-
frequency ventilation (Copland et al., 2003).
As severe sepsis is one of known causes for developing
ARDS, there is a need to understand the role of nitrosative
stress in sepsis. According to Mühl et al. (2011), severe sep-
sis is accompanied by oxidative stress and pathological leu-
kocyte endothelial cell interactions, as the laboratory pa-
rameters used for the evaluation of sepsis and several
markers of pro- and antioxidant status differ between sepsis
and non-sepsis burn patients. The tendency of changes in
these parameters may result in major oxidative stress in de-
veloping of sepsis in burn patients; septic patients showed a
significantly elevated leucocyte count and different C-reac-
tive protein levels during a 5-day period (Mühl et al., 2011).
Oxidative stress is a major contributing factor to the high
mortality rates associated with severe sepsis and many other
diseases associated with major inflammation (Everton et al.,
2009). Previous studies have confirmed severe oxidative
stress in sepsis patients, demonstrating reduced plasma, to-
tal antioxidant capacity, and elevated levels of malondialde-
hyde and 4-hydroxynonenal. Oxidative stress caused by
sepsis induces an imbalance between the production of free
radicals and endogenous available antioxidants (Alonso de
Vega et al., 2002).
Diseases in which high levels of protein carbonyl (PC)
groups have been observed include Alzheimer’s disease,
rheumatoid arthritis, diabetes, sepsis, chronic renal failure,
and respiratory distress syndrome (Dale-Donne et al.,
2003). Protein carbonyl groups (aldehydes and ketones) are
produced on protein side chains in oxidised condition.
These molecules are described as chemically stable species,
compared with those mentioned above, which can be use-
ful for their detection to predict disease. Increased
concentrations of protein carbonyls have been documented
in ARDS patients (Sittipunt et al., 2001). The carbonyl con-
tent of broncho-alveolar lavage (BAL) fluid proteins were
observed to be significantly increased in patients with diag-
nosed ARDS (5.0 F 1.3 nmol carbonyl/ml BAL fluid, p =
0.0004) and moderately increased in patients at risk for de-
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veloping ARDS caused by coronary bypass surgery (1.3 F
0.2 nmol/ ml, p = 0.027), compared with a control group
(0.8 F 0.2 nmol/ ml) (Lenz et al., 1999). In addition, there
are a large number of potential oxidative modifications, of
which only a few have been systematically studied, for ex-
ample the already mentioned protein carbonyl group prod-
ucts.
Acute respiratory distress syndrome is associated with a
complicated process of ROS expression, NO generation and
consumption. Concentrations of NO molecules will differ in
the unstable changing cytokine environment according to
the origin of airway inflammation followed by neutrophil
activation, production of reactive oxygen species and acid-
ity of endothelial and epithelial cells (Marczin and
Royston, 2001).
ANTIOXIDANTS
The massive production of ROS is generally inactivated by
endogenous and/or exogenous antioxidant molecules (Cui et
al., 2004).
The balance between the physiological production of ROS
and their inactivation in cells is based on effective enzy-
matic and non-enzymatic antioxidant systems (Behl et al.,
2002), as summarised in Figure 1.
As a first line of protection, preventive antioxidants act by
binding to specific promoters of oxidation and transition
metal ions, like iron and copper, which contain unpaired
electrons. As a result, the formation of free radicals is ele-
vated. Preventive antioxidants also include enzymatic anti-
oxidants like superoxide dismutase (SOD), glutathioneper-
oxidase (GPx) and catalase (CAT). These enzymes act on
specific ROS following their formation and degrade them to
less harmful products (Ccui et al., 2004; Wilcox et al.,
2004).
One of the most effective intracellular enzymatic antioxi-
dants is superoxide dismutase. This enzyme catalyses the
dismutation of the superoxide anion to molecular oxygen
and hydrogen peroxide. The H2O2 formed in this reaction is
later destroyed by the action of catalases and glutathione
peroxidases.
Catalase is a heme-containing enzyme, mainly localised in
the peroxisomes of mammalian cells, which decomposes
hydrogen peroxide to water and molecular oxygen.
Superoxide dismutases act together with catalases — at the
antioxidant forefront with a function to destroy free oxygen
radicals. In this way, these enzymes significantly decrease
the free radical concentration in the cell and minimise oxi-
dative damage causing cellular death. There are three forms
of metal-containing superoxide dismutases: SOD1 (Cu,
Zn-SOD) located in the cytoplasm, SOD2 (MnSOD) in the
mitochondria, and, finally, SOD3 (Cu, Zn-SOD) is extracel-
lular form that can be found at the production site. De-
creased SOD activity may be associated with a variety of
mutations in Cu/Zn-SOD, which can characterise several
neurodegenerative diseases (Stasser et al., 2005).
The selenium containing peroxidises, of which glutathione
peroxidase may be the most important example, catalyse the
reduction of hydroperoxides (H2O2 or ROOH) in the pres-
ence of the reduced form of glutathione (GSH) (Matés et
al., 2000), which oxidises two molecules of GSH to GSSG
(the oxidised form of glutathione), which can subsequently
be reduced to GSH again by glutathione reductase
(Nordberg et al., 2001). The tripeptide glutathione exists ei-
ther in the reduced (GSH) or oxidised (GSSG) form and is
present in all cells. Its main functions include: restoration of
oxidised proteins, detoxification of hydrogen peroxide, and
lipid hydroperoxides. Another important function provided
by glutathione is transport of amino acids through the plas-
matic membrane, regeneration of some antioxidants like 
  - tocopherols to active forms. The main clinical value
of glutathione is protection of brain tissue from oxidative
stress (Nordberg et al., 2001; Valko et al., 2006; Drake et
al., 2003; Masella et al., 2005). The glutathione level was
observed to be significantly elevated in burn trauma patients
at the first and third day after admission in ICU, while
superoxide dismutase enzyme activity showed no signifi-
cant changes among the control, sepsis and thermal injury
groups. On the other hand catalase activity was increased in
sepsis patients on the first day compared to the burn trauma
group (Mühl et al., 2011). Previous studies confirmed the
hypothesis that alveolar antioxidants may be decreased in
bronchoalveolar lavage fluid in burn patients (Comhair et
al., 2002).
Previous study (Schmidt et al., 2004) showed that ARDS
patients had increased neutrophil and decreased macro-
phage counts in the broncho-alveolar lavage fluid. Total
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Fig. 1. Formation of reactive oxygen and nitrogen species and some of the
endogenous antioxidant defence mechanisms. SOD, superoxide dismutase;
GSH, reduced glutathione; GSSG, oxidised glutathione; GPx, glutathione
peroxidase.
BALF protein was highly elevated in ARDS, while total
phospholipid levels did not differ significantly between pa-
tients and controls. In healthy controls, GSH was the most
common antioxidant molecule. Patients with ARDS (0.13
mM) showed higher concentrations of GSSG compared
with controls (0.03 mM). F2-isoprostane levels, as markers
for lipid peroxidation, were significantly elevated in ARDS
patients, indicating oxidant stress. The concentration of
GSH was not different in ARDS as compared with controls.
The analysis of -tocopherol showed a significant increase
in ARDS patients. When the patients with ARDS were di-
vided into primary ARDS and secondary ARDS group, only
minor differences were observed in GSH levels (Schmidt et
al., 2004).
Another study performed by Sakr and co-workers (Sakr et
al., 2007) shows the relation of selenium levels to sepsis
and SIRS. On ICU admission, 92% of patients had plasma
selenium levels below 74 	g/L — which is the reference
level for healthy patients. Plasma selenium levels showed a
decrease in all patients with SIRS, especially when associ-
ated with sepsis, despite 100 	g/day administration of sele-
nium. The degree of organ dysfunction appeared to be a ma-
jor factor explaining the drop in selenium concentration. A
plasma selenium level of 36 	g/L was found to predict ICU
mortality with high sensitivity and specificity. Serum sele-
nium levels were low in all groups of patients compared to
those of controls, but the greatest decrease was seen in the
patients with severe organ failure, especially in those with
established infection.
In conclusion, dynamic changes of oxidative and antioxida-
tive markers are not clearly understood in critically ill pa-
tients with acute respiratory failure and as a result in acute
respiratory distress syndrome. A variety of contradicting
data have been published in recent and previous studies, and
no consensus have been found yet. As a result, oxidative
stress is a wide field for investigations and improvements
by scientists and clinical experts.
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OKSIDATÎVÂ STRESA MARÍIERU LOMA AKÛTA RESPIRATORA DISTRESA SINDROMA ATTÎSTÎBÂ
Akûts respirators distresa sindroms (ARDS) ir bieþi sastopams, multifaktoriâls iekaisîgas dabas plauðu audu bojâjums, kas saistâs ar izteiktu
komorbiditâti un augstu mirstîbu intensîvâs terapijas pacientu vidû. Nesen pçtnieki pârskatîja ARDS diagnostiskos kritçrijus kopð
1994. gada. Paðlaik ARDS tiek diagnosticçts, izmantojot Berlînes definîcijas kritçrijus. Svarîga loma ARDS attîstîbâ ir oksidantu un
antioksidantu lîdzsvara traucçjumiem. Patoìençzç liela nozîme piemît tâ saucamajâm reaktîvajâm skâbekïa daïiòâm. Dinamiskâ ARDS
attîstîbai ir vairâku faktoru ietekme, lîdz ar to jâlieto individuâla pieeja katram pacientam, kas saistâs ar apgrûtinâtu prognozi un tâlâkâs
ârstçðanas taktikas izvçlç. Reaktîvâs skâbekïa daïiòas uzsâk ðûnu bojâeju, izmainot lipîdus, olbaltumvielas un DNS, kas nopietni apdraud
ðûnu turpmâko dzîvotspçju, kas savukârt sekmç sekundâro reaktîvo daïiòu izdalîðanâs un ðûnu nâvi apoptozes vai nekrozes dçï. Pçtîjumi
parâda, ka daudziem pacientiem ar orgânu mazspçju, iestâjoties intensîvajâ terapijâ, raksturîga pazeminâta antioksidantu aktivitâte, kas
pastiprina lipîdu peroksidâcijas izraisîtos negatîvos efektus. Minçtie fakti pierâda nepiecieðamîbu pçc iespçjas sekmîgâk un agrînâk
prognozçt ARDS attîstîbu un turpmâko gaitu kritiski slimiem pacientiem.
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